Lacticaseibacillus rhamnosus GR-1™ and Limosilactobacillus reuteri RC-14™ are among the most extensively studied probiotic strains in the world for women’s urogenital health. GR-1™ was isolated from the distal urethra of a healthy woman; RC-14™ from the vaginal tract of a healthy woman. Together, they are supported by 60+ scientific publications and more than 25 clinical trials. Bio-K+ Women’s Health Capsules contain 2 billion CFU, guaranteed until the expiration date.

A healthy vaginal microbiome is dominated by Lactobacillus species that maintain a protective acidic environment. When this community of microorganisms is disrupted, vaginal flora health can be affected. Daily use of GR-1™ and RC-14™ is intended to support this balance as part of a wellness routine.* Consult a healthcare practitioner if you are experiencing active or recurring symptoms.

Oral probiotics taken by mouth and vaginal suppositories inserted directly are the two main delivery formats used in clinical research on vaginal health. GR-1™ and RC-14™ have been studied in more than 25 clinical trials as oral strains. Bio-K+ Women’s Health Capsules are oral capsules. A healthcare practitioner can advise on the most appropriate format for your individual situation.

Bio-K+ Women’s Health Capsules are taken orally, 1 capsule 1 to 2 times per day, or as recommended by a healthcare practitioner. Consistent daily use matters for all probiotic categories, and individual outcomes vary based on health status, diet, and lifestyle. Consult your healthcare practitioner for guidance on a duration appropriate to your specific needs.

Three criteria identify a well-researched women’s probiotic. First, both GR-1™ and RC-14™ strain codes must appear by name on the label. Second, the CFU count must be guaranteed until the expiration date. Third, the product should be backed by peer-reviewed clinical evidence, including 60+ scientific publications and more than 25 clinical trials supporting GR-1™ and RC-14™.